pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    SKL-20540
    Cognitive Impairment Associated With Schizophrenia (CIAS) SK Life Science Inc
  • Phase 1
    SKL-24741
    Epilepsy SK Life Science Inc
  • SKYRIZI
    SKYRIZI (RISANKIZUMAB-RZAA)
    1 INDICATIONS AND USAGE SKYRIZI is an interleukin-23 anta…$ABBV AbbVie Inc.
  • Phase 1
← prev
page 156 of 271
next →
Pain89
Neurology1
SL-325
Crohn's Disease (Regional Enteritis)
$STTK Shattuck Labs, Inc.
  • Phase 2
    SL-701
    Recurrent Glioblastoma Multiforme (GBM) Stemline Therapeutics Inc
  • Preclinical
    SLATEV-3
    Unspecified Cancer Nexoplex Bio LLC
  • Preclinical
    SLEN-47
    Solid Tumor Gencirq Inc
  • Phase 2
    SLIF-06
    Hypertrophic Scars Scarless Laboratories Inc
  • Phase 1
    SLV-213
    Coronavirus Disease 2019 (COVID-19) Selva Therapeutics Inc
  • Preclinical
    SM-06
    Neuromyelitis Optica (Devic's Syndrome) SinoMab Bioscience Ltd
  • Phase 2
    SMART-101
    Refractory Acute Myeloid Leukemia Smart Immune SAS
  • Preclinical
    SMB-603
    Traumatic Brain Injury Symbinas Pharmaceuticals Inc
  • Preclinical
    SMB-604
    Traumatic Brain Injury Symbinas Pharmaceuticals Inc
  • SMOFLIPID
    SMOFLIPID
    no indication FRESENIUS KABI USA
  • Phase 2
    SMP-3124
    Anal Cancer Sumitomo Pharma Co Ltd
  • Preclinical
    SMTM-01
    Duchenne Muscular Dystrophy Cellular Intelligence Inc
  • Preclinical
    SN-40X
    Type 2 Diabetes Senseion Therapeutics Inc
  • Phase 2
    SN-514
    Burns SERDA Therapeutics BV
  • Phase 1
    SNA-11
    Synxyrin
    Treatment Resistant Depression SyneuRx International (Taiwan) Corp
  • Phase 2
    SNB-011
    Pentarlandir
    Coronavirus Disease 2019 (COVID-19) SyneuRx International (Taiwan) Corp
  • Preclinical
    SND-006
    Inflammatory Bowel Disease Jiangsu Sinorda Biomedicine Co Ltd
  • Phase 2
    SND-51
    Dementia SyneuRx International (Taiwan) Corp
  • Phase 1
    SNG-1153
    Hepatocellular Carcinoma Shenogen Pharma Group Ltd
  • Phase 3
    SNG-12
    Depression SyneuRx International (Taiwan) Corp
  • Preclinical
    SNH-110
    Unspecified Cancer ScinnoHub Pharmaceutical Co Ltd
  • Phase 2
    SNIPR-001
    Escherichia coli Infections SNIPR Biome ApS
  • Phase 1
    SNK-02
    Angiosarcoma NKGen Biotech Inc
  • Phase 2
    SNP-610
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Sinew Pharma Inc
  • Phase 1
    SNP-630
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Sinew Pharma Inc
  • Phase 2
    SNS-812
    Coronavirus Disease 2019 (COVID-19) Oneness Biotech Co Ltd